Form 483

Command Medical Products LLC Form 483, 2010-11-11

FDA issued a Form 483 to Command Medical Products LLC on 2010-11-11 with 11 public-safe observations.

483· Form 483 issued11 observations

Command Medical Products LLC · Ormond Beach, United States · Issued November 11, 2010

Overview

  • 11 public-safe observations are available for this inspection.
  • 11 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

11 Nov 2010
21 CFR 820.30(g)

Design validation - simulated testing

Cited by Leo J Lagrotte

11 Nov 2010
21 CFR 820.70(a)

Production processes

Cited by Leo J Lagrotte

11 Nov 2010
21 CFR 820.70(c)

Environmental control Lack of or inadequate procedures

Cited by Leo J Lagrotte

11 Nov 2010
21 CFR 820.70(d)

Implementing Personnel Procedures, Health, Cleanliness.

Cited by Leo J Lagrotte

11 Nov 2010
21 CFR 820.70(g)(3)

Adjustment

Cited by Leo J Lagrotte

Inspected site

CMCommand Medical Products LLCOrmond Beach, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 820.100(a)Cited across public-safe Form 483 observations1x
21 CFR 820.198(a)Cited across public-safe Form 483 observations1x
21 CFR 820.30(g)Cited across public-safe Form 483 observations1x
21 CFR 820.70(a)Cited across public-safe Form 483 observations1x
21 CFR 820.70(c)Cited across public-safe Form 483 observations1x
21 CFR 820.70(d)Cited across public-safe Form 483 observations1x
21 CFR 820.70(g)(3)Cited across public-safe Form 483 observations1x
21 CFR 820.72(a)Cited across public-safe Form 483 observations1x
21 CFR 820.80(b)Cited across public-safe Form 483 observations1x
21 CFR 820.80(c)Cited across public-safe Form 483 observations1x
21 CFR 820.90(a)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 11 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere